🇬🇧 General Pharmaceutical Council Registration Assessment (GPhC Assessment) · subject
General Pharmaceutical Council Registration Assessment (GPhC Assessment) Clinical Therapeutics and Disease Management Syllabus
The Clinical Therapeutics and Disease Management syllabus for General Pharmaceutical Council Registration Assessment (GPhC Assessment) in full: 5 chapters, 23 topics and 42 sub-topics, every one listed below, plus 61 Clinical Therapeutics and Disease Management flashcards with answers.
Clinical Therapeutics and Disease Management syllabus: all 5 chapters
Expand any chapter to see its topics and sub-topics.
-
Cardiovascular System
5 topics- Hypertension
- ACE inhibitors, ARBs, calcium-channel blockers and diuretics
- NICE/BHS step-wise treatment algorithm
- Heart Failure
- Guideline-directed medical therapy
- Monitoring and titration
- Ischaemic Heart Disease and Acute Coronary Syndrome
- Antiplatelets and dual antiplatelet therapy
- Secondary prevention
- Anticoagulation and Atrial Fibrillation
- Warfarin and INR monitoring
- DOACs and CHA2DS2-VASc/ORBIT scoring
- Lipid Modification
- Statin intensity and QRISK
- Adjuncts and intolerance management
- Hypertension
-
Respiratory, Endocrine and Metabolic
4 topics- Asthma
- BTS/SIGN/NICE stepwise management
- Inhaler technique and devices
- COPD
- Bronchodilator and ICS use
- Exacerbation management
- Diabetes Mellitus
- Type 1 and Type 2 treatment pathways
- Insulin regimens and hypoglycaemia
- Sick-day rules and SGLT2 inhibitor cautions
- Thyroid Disorders
- Levothyroxine dosing and monitoring
- Antithyroid drugs
- Asthma
-
Gastrointestinal, Renal and Genitourinary
5 topics- Dyspepsia, GORD and Peptic Ulcer Disease
- PPIs, H2 antagonists and H. pylori eradication
- Inflammatory Bowel Disease and IBS
- Aminosalicylates and biologics overview
- Constipation and Diarrhoea
- Laxative classes and selection
- Chronic Kidney Disease
- Drug handling and dose adjustment
- Nephrotoxin avoidance
- Urinary Tract Infections and Continence
- Antibiotic selection and resistance
- Dyspepsia, GORD and Peptic Ulcer Disease
-
Central Nervous System and Mental Health
5 topics- Depression and Anxiety
- SSRIs, SNRIs and serotonin syndrome
- Switching and withdrawal
- Psychosis and Bipolar Disorder
- Antipsychotics and monitoring
- Lithium therapeutic range and toxicity
- Epilepsy
- Anti-epileptic drug selection
- Pregnancy risks (valproate) and brand consistency
- Pain and Palliative Care
- WHO analgesic ladder
- Opioid conversion and breakthrough dosing
- Parkinson's Disease and Dementia
- Levodopa and timing of doses
- Depression and Anxiety
-
Infection, Immunology and Malignancy
4 topics- Antimicrobial Therapy
- Antibiotic classes and spectrum
- Antimicrobial stewardship and resistance
- Specific Infections
- Sepsis recognition and Sepsis Six
- Tuberculosis and HIV overview
- Vaccination and Immunisation
- UK immunisation schedule
- Patient Group Directions for vaccines
- Oncology and Supportive Care
- Cytotoxic handling and extravasation
- Managing nausea and neutropenia
- Antimicrobial Therapy
General Pharmaceutical Council Registration Assessment (GPhC Assessment) Clinical Therapeutics and Disease Management flashcards — 61 questions with answers
According to NICE, what blood pressure reading (clinic) defines Stage 1 hypertension, and what threshold confirms it on ambulatory/home monitoring (ABPM/HBPM)?
Stage 1 hypertension is a clinic BP of $\geq 140/90$ mmHg, confirmed by an ABPM/HBPM average of $\geq 135/85$ mmHg.
In the NICE hypertension treatment algorithm, what is first-line therapy for a patient aged under 55 with no type 2 diabetes, versus a patient who is over 55 or of Black African/Caribbean origin?
Under 55 without type 2 diabetes (or any patient with type 2 diabetes): an ACE inhibitor or ARB. Over 55 or Black African/Caribbean (without diabetes): a calcium channel blocker (CCB).
What is the recommended clinic blood pressure treatment target for a hypertensive patient aged under 80, and for a patient aged 80 or over?
Under 80: clinic BP target $<140/90$ mmHg. Aged $\geq 80$: clinic BP target $<150/90$ mmHg.
In step 4 (resistant) hypertension, how does NICE guide the choice of add-on therapy based on serum potassium?
If potassium is $\leq 4.5$ mmol/L, add low-dose spironolactone (off-label). If potassium is $>4.5$ mmol/L, add an alpha- or beta-blocker instead (higher hyperkalaemia risk with spironolactone).
What are the four pharmacological pillars of guideline-directed therapy for heart failure with reduced ejection fraction (HFrEF)?
ACE inhibitor (or ARB)/ARNI, beta-blocker, mineralocorticoid receptor antagonist (spironolactone/eplerenone), and an SGLT2 inhibitor (dapagliflozin/empagliflozin).
Which three beta-blockers are licensed for the treatment of heart failure in the UK?
Bisoprolol, carvedilol, and nebivolol (nebivolol licensed in stable mild-to-moderate HF in patients $\geq 70$ years).
What is sacubitril/valsartan (an ARNI), and what important washout is required when switching from an ACE inhibitor?
It combines a neprilysin inhibitor (sacubitril) with an ARB (valsartan), used in HFrEF. A 36-hour washout is needed between stopping an ACE inhibitor and starting it, to avoid angioedema.
In acute coronary syndrome, how is STEMI distinguished from NSTEMI/unstable angina on initial assessment?
STEMI shows persistent ST-elevation (or new LBBB) on ECG, requiring immediate reperfusion. NSTEMI shows raised troponin without ST-elevation; unstable angina has ischaemic symptoms with normal troponin.
What is the standard secondary-prevention drug regimen after a myocardial infarction (the 'cardioprotective' combination)?
Dual antiplatelet therapy (aspirin plus a P2Y12 inhibitor such as ticagrelor/clopidogrel/prasugrel), a beta-blocker, an ACE inhibitor, and a high-intensity statin (atorvastatin 80 mg).
What is the standard immediate ('MONA'-type) management for a patient presenting with a STEMI awaiting reperfusion?
Aspirin 300 mg loading dose, a second antiplatelet (e.g. ticagrelor/prasugrel), pain relief with GTN and IV morphine, anti-emetic, and oxygen only if $\text{SpO}_2 < 94\%$. Primary PCI is the preferred reperfusion.
For most patients with non-valvular atrial fibrillation, which class of anticoagulant does NICE now recommend first-line over warfarin?
A direct oral anticoagulant (DOAC) such as apixaban, rivaroxaban, edoxaban, or dabigatran is recommended first-line in preference to warfarin.
State the components of the CHA₂DS₂-VASc score used to assess stroke risk in atrial fibrillation.
Congestive HF (1), Hypertension (1), Age $\geq 75$ (2), Diabetes (1), prior Stroke/TIA/thromboembolism (2), Vascular disease (1), Age 65–74 (1), Sex category female (1).
What does the ORBIT (or HAS-BLED) score assess in atrial fibrillation management, and what is its purpose?
It estimates bleeding risk on anticoagulation. Its purpose is to identify and correct modifiable bleeding risk factors, NOT to withhold anticoagulation.
What is the target INR range for most patients on warfarin (e.g. AF, DVT/PE treatment), and which clotting factors does warfarin inhibit?
Target INR is typically $2.5$ (range $2.0$–$3.0$). Warfarin inhibits vitamin K–dependent clotting factors II, VII, IX and X (and proteins C and S).
In primary prevention of cardiovascular disease, at what QRISK3 10-year risk threshold does NICE recommend offering a statin, and which statin/dose?
Offer atorvastatin 20 mg when the QRISK3 10-year CVD risk is $\geq 10\%$.
What is the NICE target reduction in non-HDL cholesterol after starting a statin for primary prevention, assessed at 3 months?
A greater than $40\%$ reduction in non-HDL cholesterol from baseline.
What statin and dose is used for secondary prevention of CVD, and what non-statin add-on options exist if targets are not met?
Atorvastatin 80 mg for secondary prevention. Add-ons include ezetimibe, then PCSK9 inhibitors (alirocumab/evolocumab), bempedoic acid, or inclisiran.
In the SIGN/BTS-NICE asthma pathway, what defines good control assessed by inhaler step-up, and what is the modern preferred reliever approach (MART)?
MART (Maintenance And Reliever Therapy) uses a single combination inhaler of an inhaled corticosteroid plus formoterol for both daily maintenance and as-needed relief, replacing a separate SABA reliever.
List the features used to assess severity of an acute asthma attack distinguishing 'acute severe' from 'life-threatening'.
Acute severe: PEF 33–50% best/predicted, RR $\geq 25$, HR $\geq 110$, unable to complete sentences. Life-threatening: PEF $<33\%$, $\text{SpO}_2 <92\%$, silent chest, cyanosis, exhaustion, hypotension, normal/rising $\text{PaCO}_2$.
What spirometry result confirms a diagnosis of COPD?
A post-bronchodilator $\text{FEV}_1/\text{FVC}$ ratio $<0.7$ (i.e. $<70\%$), indicating persistent airflow obstruction.
Show the other 41 Clinical Therapeutics and Disease Management flashcards
In COPD, how does the presence of 'asthmatic features / steroid responsiveness' change the choice of inhaled maintenance therapy?
With asthmatic/steroid-responsive features, escalate to LABA + ICS (then LAMA + LABA + ICS). Without them, escalate to LABA + LAMA. ICS adds pneumonia risk so is reserved for those features or frequent exacerbations.
What is the typical management of an acute infective COPD exacerbation in terms of drug therapy?
Increase short-acting bronchodilators, a short course of oral prednisolone 30 mg for 5 days, and an antibiotic (e.g. amoxicillin, doxycycline, or clarithromycin) if sputum is purulent or there are signs of pneumonia.
What HbA1c value diagnoses type 2 diabetes, and what range defines 'pre-diabetes' (non-diabetic hyperglycaemia)?
Diabetes is diagnosed at HbA1c $\geq 48$ mmol/mol ($6.5\%$). Non-diabetic hyperglycaemia is HbA1c 42–47 mmol/mol.
What is first-line drug therapy for type 2 diabetes, and what is now recommended in addition for patients with established CVD or heart failure?
First-line is metformin (standard-release, titrated). For those with established/high-risk CVD, chronic HF, or CKD, add an SGLT2 inhibitor with proven cardiovascular benefit.
What are the typical HbA1c targets for a type 2 diabetic managed by lifestyle/single drug versus one on a drug carrying hypoglycaemia risk (e.g. sulfonylurea)?
Target is 48 mmol/mol ($6.5\%$) on lifestyle or a non-hypoglycaemic drug; relax to 53 mmol/mol ($7.0\%$) when on a drug that can cause hypoglycaemia.
What is the biochemical triad defining diabetic ketoacidosis (DKA)?
Hyperglycaemia (blood glucose $>11$ mmol/L or known diabetes), ketonaemia ($\geq 3$ mmol/L) or significant ketonuria, and acidosis (venous pH $<7.3$ or bicarbonate $<15$ mmol/L).
How do you interpret thyroid function tests in primary hypothyroidism versus primary hyperthyroidism?
Primary hypothyroidism: high TSH with low free T4. Primary hyperthyroidism: suppressed (low) TSH with high free T4 and/or T3.
What is the first-line drug for hypothyroidism, how is it monitored, and what counselling point governs absorption?
Levothyroxine, titrated to normalise TSH (rechecked $\geq 4$–8 weeks after dose change). Take on an empty stomach, separated from calcium/iron and food, which impair absorption.
Name the two main antithyroid drugs for hyperthyroidism and the key serious adverse effect patients must be warned about.
Carbimazole (first-line) and propylthiouracil. Warn about agranulocytosis: seek urgent help and a white-cell count if sore throat, fever, or mouth ulcers develop.
For uninvestigated dyspepsia/GORD, what are the two main initial pharmacological strategies after lifestyle advice?
A full-dose proton pump inhibitor for 4–8 weeks, or 'test and treat' for Helicobacter pylori. Review and step down to the lowest effective dose.
What is standard first-line triple therapy for Helicobacter pylori eradication in a penicillin-tolerant patient?
A 7-day course of a PPI (twice daily) plus amoxicillin plus either clarithromycin or metronidazole. In penicillin allergy: PPI + clarithromycin + metronidazole.
Which drug classes most commonly cause or worsen peptic ulcers, and what is the typical gastroprotection strategy?
NSAIDs and aspirin (and corticosteroids/anticoagulants increase bleeding risk). Co-prescribe a PPI for gastroprotection in at-risk patients, and use the lowest effective NSAID dose.
How does the typical distribution and inflammation pattern of ulcerative colitis differ from Crohn's disease?
Ulcerative colitis: continuous mucosal inflammation limited to the colon, starting at the rectum. Crohn's: transmural, patchy ('skip lesions') inflammation anywhere from mouth to anus, often terminal ileum.
What drug classes are used to induce versus maintain remission in mild-to-moderate ulcerative colitis?
Aminosalicylates (mesalazine/sulfasalazine), topical and/or oral, induce and maintain remission. Corticosteroids induce remission in flares but are NOT used for maintenance.
What is the recommended first-line antispasmodic/symptom approach for irritable bowel syndrome (IBS), and which antidepressant class is used second-line?
First-line: antispasmodics (e.g. mebeverine, hyoscine) with dietary/fibre advice; loperamide for diarrhoea, laxatives (avoid lactulose) for constipation. Second-line: a low-dose tricyclic antidepressant, then SSRI.
Classify the four main laxative groups with an example of each.
Bulk-forming (ispaghula husk), osmotic (macrogol, lactulose), stimulant (senna, bisacodyl), and stool softeners/faecal softeners (docusate, glycerin). Bulk-forming is usually first-line for chronic constipation.
In acute infective diarrhoea, when is an antimotility drug such as loperamide contraindicated?
Avoid loperamide if there is bloody diarrhoea, high fever, or suspected/confirmed colitis (e.g. C. difficile, severe Shigella/E. coli O157), as it risks toxic megacolon and prolongs infection.
How is chronic kidney disease classified, and which two parameters define the stage?
CKD is staged by GFR category (G1–G5, by eGFR) and albuminuria category (A1–A3, by albumin:creatinine ratio). Lower eGFR and higher ACR indicate worse disease and risk.
Which drug classes provide reno-protection in CKD with albuminuria, and what monitoring is needed after initiation?
ACE inhibitors/ARBs (titrated to maximum tolerated dose) and SGLT2 inhibitors. Check renal function and potassium 1–2 weeks after starting/uptitrating; a rise in creatinine up to $30\%$ or eGFR fall up to $25\%$ can be acceptable.
Name three common drug classes that require dose reduction or avoidance in significant renal impairment.
Examples: metformin (lactic acidosis risk), DOACs and LMWH (bleeding), gabapentin/pregabalin, opioids (morphine), nitrofurantoin (avoid if eGFR $<45$), and many antibiotics (e.g. aminoglycosides, vancomycin).
What is first-line antibiotic therapy for an uncomplicated lower UTI in a non-pregnant woman per NICE/PHE?
Nitrofurantoin (if eGFR $\geq 45$) for 3 days, or trimethoprim if low resistance risk. Nitrofurantoin is avoided near term in pregnancy; trimethoprim is avoided in the first trimester (folate antagonist).
How do the drug treatments for overactive bladder (urge incontinence) differ from those for stress urinary incontinence?
Urge/OAB: antimuscarinics (oxybutynin, tolterodine, solifenacin) or the beta-3 agonist mirabegron. Stress incontinence: pelvic floor exercises first-line; duloxetine is an option if surgery is declined.
What is the recommended minimum duration of antidepressant treatment after remission of a first episode of depression, and which class is first-line?
Continue for at least 6 months after remission (longer if recurrent/high-risk). A generic SSRI (e.g. sertraline, citalopram) is first-line.
What is serotonin syndrome and what triad of features characterises it?
A potentially life-threatening reaction from excess serotonergic activity (e.g. SSRI + MAOI/tramadol). Triad: neuromuscular excitation (clonus, hyperreflexia, rigidity), autonomic instability (fever, tachycardia), and altered mental state.
Which drug is the gold-standard mood stabiliser for bipolar disorder, and what therapeutic plasma range and toxicity signs must be monitored?
Lithium. Therapeutic range is $0.4$–$1.0$ mmol/L (target often $0.6$–$0.8$), taken 12 hours post-dose. Toxicity ($>1.5$ mmol/L): coarse tremor, ataxia, confusion, seizures; needs regular U&Es and thyroid monitoring.
What is the key metabolic monitoring required for patients on second-generation (atypical) antipsychotics, and why is clozapine special?
Monitor weight, lipids, glucose/HbA1c, and prolactin due to metabolic effects. Clozapine requires mandatory regular full blood count monitoring because of the risk of agranulocytosis/neutropenia.
What is first-line monotherapy for focal (partial) seizures versus generalised tonic-clonic seizures under current MHRA guidance for men/non-childbearing patients?
Focal seizures: lamotrigine or levetiracetam. Generalised tonic-clonic: sodium valproate (but NOT in those able to bear children); lamotrigine or levetiracetam are alternatives.
What are the MHRA pregnancy-prevention requirements around sodium valproate?
Valproate must not be used in anyone able to become pregnant unless conditions of the Pregnancy Prevention Programme are met (high teratogenicity: neural tube defects, neurodevelopmental disorders), with annual specialist review and effective contraception.
Describe the WHO analgesic ladder for pain management.
Step 1: non-opioid (paracetamol $\pm$ NSAID). Step 2: weak opioid (codeine, dihydrocodeine) $\pm$ non-opioid. Step 3: strong opioid (morphine) $\pm$ non-opioid, with adjuvants (e.g. amitriptyline, gabapentin) at any step.
How do you convert oral morphine to subcutaneous morphine and to oral codeine (approximate equivalences)?
Oral to subcutaneous morphine: divide the oral dose by 2. Oral codeine to oral morphine: divide the codeine dose by about 10 (codeine is roughly one-tenth as potent).
What is the first-line drug treatment for idiopathic Parkinson's disease when motor symptoms affect quality of life?
Levodopa (combined with a dopa-decarboxylase inhibitor, e.g. co-careldopa or co-beneldopa). Dopamine agonists or MAO-B inhibitors are alternatives if motor symptoms are not affecting quality of life.
Which class of medication should be avoided in dementia with Lewy bodies and Parkinson's disease dementia, and which drug class is first-line for cognitive symptoms?
Avoid antipsychotics (risk of severe sensitivity reactions). Acetylcholinesterase inhibitors (donepezil, rivastigmine, galantamine) are first-line for cognition; memantine (NMDA antagonist) for moderate-severe or intolerance.
What general principles guide empirical antimicrobial therapy and good antimicrobial stewardship?
Use the narrowest-spectrum effective agent guided by local resistance/sensitivities, prescribe the shortest effective course, review/de-escalate at 48–72 hours, take cultures before starting where possible, and document indication, dose and review/stop date.
Which antibiotics carry an MHRA warning for tendon damage/aortic aneurysm, and which class is associated with C. difficile and QT prolongation?
Fluoroquinolones (e.g. ciprofloxacin) carry warnings for tendon rupture and aortic aneurysm. Broad-spectrum agents (cephalosporins, co-amoxiclav, clindamycin, quinolones) raise C. difficile risk; macrolides and quinolones prolong the QT interval.
What is the standard antibiotic management of community-acquired pneumonia stratified by CURB-65 severity?
CURB-65 0–1 (low): oral amoxicillin (or doxycycline/macrolide). 2 (moderate): amoxicillin + macrolide. $\geq 3$ (severe): IV co-amoxiclav + macrolide, consider hospital/ITU. CURB-65 = Confusion, Urea $>7$, RR $\geq 30$, BP $<90/60$, age $\geq 65$.
What is the empirical treatment approach for suspected bacterial meningitis in the community before hospital transfer?
Give immediate IM/IV benzylpenicillin (unless true penicillin anaphylaxis) and arrange urgent hospital admission; in hospital, IV ceftriaxone/cefotaxime (add amoxicillin for Listeria cover in the very young, elderly, or immunocompromised), plus dexamethasone.
Distinguish a live attenuated vaccine from an inactivated vaccine, and give an example and key contraindication of each.
Live attenuated (e.g. MMR, varicella, nasal flu): weakened organism, generally avoided in significant immunosuppression and pregnancy. Inactivated (e.g. injectable flu, hepatitis B, tetanus): killed/subunit, safe in immunosuppression but may need boosters.
Which vaccines are offered routinely to adults in the UK based on age/risk (give examples), and what is the key counselling point about timing in immunosuppression?
Examples: annual influenza, pneumococcal (PPV23 at 65+/at-risk), shingles (Shingrix), COVID-19, and RSV (75+/late pregnancy). Live vaccines should ideally be given before starting, or after stopping, immunosuppressive therapy.
In cancer chemotherapy, what is neutropenic sepsis and how must it be managed?
A medical emergency: fever (or unwell) with neutrophils $\leq 0.5 \times 10^{9}$/L (or $\leq 1.0$ and falling) within ~6 weeks of chemotherapy. Treat immediately with empirical broad-spectrum IV antibiotics (e.g. piperacillin/tazobactam) without waiting for cultures.
What anti-emetic strategy is used for highly emetogenic chemotherapy, and which receptor is targeted by ondansetron?
Combine a 5-HT3 antagonist (ondansetron), a corticosteroid (dexamethasone), and an NK1 receptor antagonist (aprepitant). Ondansetron blocks 5-HT3 (serotonin) receptors; note its risk of constipation and QT prolongation.
What is tumour lysis syndrome, and which biochemical abnormalities define it?
A metabolic emergency from rapid tumour cell breakdown (often after starting chemo in bulky/haematological cancers): hyperkalaemia, hyperphosphataemia, hyperuricaemia, and secondary hypocalcaemia, risking AKI. Managed with hydration and allopurinol or rasburicase.
General Pharmaceutical Council Registration Assessment (GPhC Assessment) Clinical Therapeutics and Disease Management FAQ
What is in the General Pharmaceutical Council Registration Assessment (GPhC Assessment) Clinical Therapeutics and Disease Management syllabus?
General Pharmaceutical Council Registration Assessment (GPhC Assessment) Clinical Therapeutics and Disease Management is split into 5 chapters: Cardiovascular System, Respiratory, Endocrine and Metabolic, Gastrointestinal, Renal and Genitourinary, Central Nervous System and Mental Health and Infection, Immunology and Malignancy. Together they contain 23 topics and 42 sub-topics.
How many chapters are in General Pharmaceutical Council Registration Assessment (GPhC Assessment) Clinical Therapeutics and Disease Management?
5 chapters, containing 23 topics and 42 sub-topics. The largest chapter is Cardiovascular System, with 5 topics.
Are there flashcards for General Pharmaceutical Council Registration Assessment (GPhC Assessment) Clinical Therapeutics and Disease Management?
Yes — a 61-card Clinical Therapeutics and Disease Management deck, printed in full in the flashcards section of this page and available in the Examius app with spaced repetition. The free plan covers one exam of your choice, including its flashcards; Examius Pro, a one-time purchase, unlocks every other exam and deck.